EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deep learning‐based MRI analysis reveals Lewy body co‐pathology accelerates brain aging in Alzheimer's disease

Babak Ahmadi, Melissa Armstrong, Breton M Asken, Mostafa Reisi-Gahrooei, Abbas Babajani-Feremi, Alzheimer's Disease Neuroimaging Initiative, Australian Imaging Biomarkers and Lifestyle flagship study of ageing

Alzheimer's & Dementia · 2026-07 · 22 (7)

DOI: 10.1002/alz.71593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 15.07.2026. Verfasst von Babak Ahmadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial and Systems Engineering, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Magnetic Resonance Imaging, Brain, Aging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIMH NIH HHS, Mangurian-Fixel-McKnight Collaboration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Lewy body (LB) co‐pathology is common in Alzheimer's disease (AD), yet its in vivo impact on neurodegeneration remains unclear. METHODS We trained a 3D‐DenseNet on multi‐cohort T1‐weighted magnetic resonance imaging (MRI) from cognitively unimpaired individuals to estimate brain age (BA) and applied it to cognitively impaired Alzheimer's Disease Neuroimaging Initiative (ADNI) participants stratified by cerebrospinal fluid (CSF) p‐tau 181 /Aβ 42 (AD) and α‐synuclein seed amplification assay (LB) status into: AD+LB+, AD+LB−, AD−LB+, and AD−LB−. We compared baseline and longitudinal brain–age gap (BAG), identified saliency‐derived anatomical contributors, assessed regional atrophy and cognition, and evaluated whether BAG explains LB‐related clinical decline within AD. RESULTS The model robustly captured normative aging. AD+LB+ exhibited the greatest and fastest‐increasing BAG, with saliency maps emphasizing regions that also showed steeper longitudinal atrophy and concordant cognitive decline, and BAG mediated a substantial portion of LB‐related cognitive impairment within AD+. DISCUSSION LB co‐pathology confers an additional neurodegenerative burden in AD, underscoring the importance of combined biomarker assessment and targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMagnetic Resonance ImagingBrainAgingDeep LearningLewy BodiesLewy Body DiseaseHumansFemaleAgedMaleAged, 80 and overalpha-SynucleinAtrophyAmyloid beta-PeptidesNeuroimagingCognitive Dysfunction

Stichwörter der Autor:innen

Alzheimer's diseaseLewy bodyMRIbrain agebrain age gapcognitive declinecognitive impairmentco‐pathologydeep learningneurodegenerationneurodegenerative burdenα‐synuclein

Substanzen

alpha-SynucleinAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Industrial and Systems Engineering, University of Florida, Gainesville, Florida, USA.
  • Department of Neurology, University of Florida, Gainesville, Florida, USA.
  • Magnetoencephalography (MEG) Lab, The Norman Fixel Institute of Neurological Diseases, University of Florida Health, Gainesville, Florida, USA.
  • Department of Clinical and Health Psychology, University of Florida, Gainesville, Florida, USA.

Förderung

  • NIA NIH HHS
  • NIMH NIH HHS
  • Mangurian-Fixel-McKnight Collaboration

Zitieren

APA

Ahmadi, B., Armstrong, M., Asken, B. M., Reisi-Gahrooei, M., Babajani-Feremi, A., Alzheimer's Disease Neuroimaging Initiative, & Australian Imaging Biomarkers and Lifestyle flagship study of ageing (2026). Deep learning‐based MRI analysis reveals Lewy body co‐pathology accelerates brain aging in Alzheimer's disease. Alzheimer's & Dementia, 22(7). https://doi.org/10.1002/alz.71593

Vancouver

Ahmadi B, Armstrong M, Asken BM, Reisi-Gahrooei M, Babajani-Feremi A, Alzheimer's Disease Neuroimaging Initiative, et al. Deep learning‐based MRI analysis reveals Lewy body co‐pathology accelerates brain aging in Alzheimer's disease. Alzheimer's & Dementia. 2026;22(7). doi:10.1002/alz.71593

BibTeX
@article{Ahmadi2026,
  author = {Ahmadi, Babak and Armstrong, Melissa and Asken, Breton M and Reisi-Gahrooei, Mostafa and Babajani-Feremi, Abbas and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative and Australian Imaging Biomarkers and Lifestyle flagship study of ageing, Australian Imaging Biomarkers and Lifestyle flagship study of ageing},
  title = {Deep learning‐based MRI analysis reveals Lewy body co‐pathology accelerates brain aging in Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {7},
  doi = {10.1002/alz.71593}
}
Kostenlos starten →